StockNews.com began coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a research note released on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Price Performance
BLPH opened at $0.04 on Tuesday. The firm has a market capitalization of $428,155.00, a P/E ratio of -0.04 and a beta of 0.73. Bellerophon Therapeutics has a one year low of $0.03 and a one year high of $0.52. The company has a fifty day moving average price of $0.05 and a 200-day moving average price of $0.05.
Bellerophon Therapeutics Company Profile
Further Reading
- Five stocks we like better than Bellerophon Therapeutics
- What is Insider Trading? What You Can Learn from Insider Trading
- Lumen: Among Top Performers Last Month, Still Has Warning Signs
- What are earnings reports?
- Baidu’s Strong Quarter Proves a Smart Pick for Michael Burry
- What Are the U.K. Market Holidays? How to Invest and Trade
- Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.